Skip to main content

Home/ Dogs-to-Stars Enterprises/ Group items tagged genomics

Rss Feed Group items tagged

dhtobey Tobey

Byte Size Biology » genomics - 1 views

  • etadata is the “data about the data”: all the habitat data, SOPs and abiotic data that is in dire need of the standardization Kyrpides writes about.
  • Metadata is the “data about the data”: all the habitat data, SOPs and abiotic data that is in dire need of the standardization Kyrpides writes about.
  • In 2005 the Genomics Standards Consortium was formed to address this problem. Renzo Kottman from the Max-Planck Institute for Marine Microbiology in Bremen, Germany  talked about software development within the GSC, and specifically about his own project: the Genomic Contextual Data Markup Language, or GCDML. GCDML is an XML-based standard for describing everything associated with a genomic or a metagenomic sample: where it was taken from , under what conditions, which protocols were used to extract, sequence, assemble, finish and analyze the metagenome.
    • dhtobey Tobey
       
      Standards organizations are community desktops waiting to happen. More specifically, not reference to "protocols" with a five step process similar to our technology transfer framework. If we could get a copy of this protocol we could develop a diagram and a community site around the four "research cycle" stages: extract, sequence, assemble, finish and analyze. What we need is a similar structure for the tissue sourcing process. Scott, can you think of who might have such a protocol documented?
  •  
    Excerpt from further down the article that Steve sent via email. Note the embedded presentation on "Software development by the Genomics Standards Consortium."
  •  
    wow.. this page is a tour de force for bio science info issues ... and I very much like where you are going with the extract, sequence, assemble, finish and analyze.. pattern.. similar to the NIST model we are using at NERC.... hopefully
dhtobey Tobey

Company plans to sell genetic testing kit at drugstores - 0 views

  • Beginning Friday
  • drugstores across the nation will be able to pick up something new: a test to scan their genes for a propensity for Alzheimer's disease, breast cancer, diabetes and other ailments.
  • The test also claims to offer a window into the chances of becoming obese, developing psoriasis and going blind. For those thinking of starting a family, it could alert them to their risk of having a baby with cystic fibrosis, Tay-Sachs and other genetic disorders. The test also promises users insights into how caffeine, cholesterol-lowering drugs and blood thinners might affect them.
  • ...3 more annotations...
  • the plan being announced Tuesday by Pathway Genomics of San Diego to sell its Insight test at about 6,000 of Walgreens' 7,500 stores represents the boldest move yet to bring the power of modern molecular medicine to the mass market.
  • The Food and Drug Administration questioned Monday whether the test will be sold legally because it does not have the agency's approval. Critics have said that results will be too vague to provide much useful guidance because so little is known about how to interpret genetic markers.
  • Others have said that the test is irresponsible and could give many buyers a dangerous false sense of security or, conversely, needlessly alarm them.
  •  
    Pioneer in genomics diagnostics may begin to pave the way for more sophisticated, FDA-approved products. Scott, How does this compare with products you have been looking at?
1 - 2 of 2
Showing 20 items per page